30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dunn Edmund

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dunn Edmund's trades of Monte Rosa Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-16 2026-04-16
PrS Proposed sale
41,196
373.10
US$3,021,835 		41,196 373.10 US$3,021,835
2026-04-13 2026-04-13
PrS Proposed sale
9,971
143.10
US$667,112 		9,971 143.10 US$667,112
2026-04-08 2026-04-08
PrS Proposed sale
559
365.96
US$919,884 		559 365.96 US$919,884
2026-03-05 2026-03-04
S Sale
139 -0.6%
17.96
US$2,496 		139 -0.6% 17.96 US$2,496
2026-03-04 2026-03-04
PrS Proposed sale
139
17.86
US$2,482 		139 17.86 US$2,482
2026-03-02 2026-03-02
S Sale
536 -2.3%
17.50
US$9,380 		536 -2.3% 17.50 US$9,380
2026-03-02 2026-03-02
PrS Proposed sale
536
17.50
US$9,380 		536 17.50 US$9,380
2026-03-02 2026-02-27
S Sale
25,164 -52.6%
18.10
US$455,506 		25,164 -52.6% 18.10 US$455,506
2026-02-27 2026-02-27
PrS Proposed sale
25,164
18.10
US$455,506 		25,164 18.10 US$455,506
2026-01-05 2026-01-05
S Sale
1,039 -4.4%
15.17
US$15,762 		1,039 -4.4% 15.17 US$15,762
2025-06-04 2025-06-03
S Sale
2,062 -8.0%
4.45
US$9,174 		2,062 -8.0% 4.45 US$9,174
2024-07-09 2024-07-05
S Sale
1,610 -10.4%
3.83
US$6,166 		1,610 -10.4% 3.83 US$6,166
2024-06-05 2024-06-03
S Sale
1,207 -7.2%
4.04
US$4,876 		1,207 -7.2% 4.04 US$4,876